Thromboembolism Archives - Oncology Nurse Advisor

cardiac ultrasound echo deep venous thrombosis

Risk of Thrombosis With Treatments for Newly Diagnosed Multiple Myeloma

By

Vicki Moore, PhD

June 16, 2020

Despite thromboprophylaxis, patients who have newly developed multiple myeloma are at an “unacceptably high VTE risk”, study results suggest.

Anticoagulant efficacy to prevent VTE after hip and knee arthroplasty

Hematologic Cancers

Clotting and COVID: New Guidelines in the Works to Treat Coagulopathies in Patients With COVID-19

By

Rita Aghjayan

May 20, 2020

Growing concerns about thromboembolic comorbidities in patients with COVID-19 is leading ASH to create clinical practice guidelines to treat this patient population.

Tinzaparin may effectively prevent VTE and major bleeding.

Myeloproliferative Neoplasms

Increased Risk of Venous Thromboembolism in Patients With Myelofibrosis

By

Susan Moench, PhD, PA-C

March 13, 2020

One finding from this study was that VTE was more likely to occur at atypical sites in patients with myelofibrosis compared to those without the disease.

Closeup of several multicolored pills in the palm of someone's hand.

Leukemia

Analysis of Thrombotic Events in Patients Receiving Ibrutinib

By

Sharon Ben Barouch, MD

October 17, 2019

Researchers found a low incidence of thrombotic events in patients receiving ibrutinib, though some patients still experienced bleeding.

Myeloproliferative Neoplasms

Expert Panel Releases Recommendations on Unmet Clinical Needs With Ph-Negative Myeloproliferative Neoplasms

By

Vicki Moore, PhD

September 5, 2019

An overview of the findings of an expert panel that examined the unmet clinical needs for patients with Ph-negative MPNs to assess for risks of thrombosis.

General Oncology

Guideline Update for Venous Thromboembolism Prophylaxis in Patients With Cancer

By

Roxanne Nelson, RN, BSN

August 29, 2019

The American Society of Clinical Oncology released updates to their guidelines for thromboprophylaxis in patients with cancer.

Researchers compared the safety and effectiveness of apixaban and rivaroxaban in patients with VTE.

Multiple Myeloma

SAVED Tool Improves Assessment of Venous Thromboembolism Risk in Patients With Multiple Myeloma

By

Susan Moench, PhD, PA-C

August 5, 2019

Retrospective population-based cohort study is used to validate a new risk assessment tool to identify patients receiving immunomodulatory drugs for multiple myeloma who may be at high risk of VTE.